USPTO Is Rejecting Potentially Life-Saving Inventions

Law360, New York (December 18, 2014, 11:05 AM EST) -- Patent law is generally not part of today's public conversation. The issues don't usually tug at our hearts, and the most hotly contested debates are both legally and technically intricate. But there is one issue that deserves the public's attention now.

Beginning in 2012, the U.S. Supreme Court issued three decisions that radically limited the type of inventions that may be patented under § 101 of the patent laws: Mayo v. Prometheus, Association for Molecular Pathology v. Myriad Genetics and Alice v. CLS Bank.[1] Although these decisions dealt with several controversial types of patents — namely, medical diagnostic, gene and software...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!